SEC Form 4/A · accession 0001053369-15-000027
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Ashok G Nigalaye
Director · 10% Owner
Period of report
Jan 6, 2015
Accepted (ET)
May 13, 2015 · 6:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantsF1 | $0.0625 | Jan 6, 2015 | C | 1,500,000 | D | Oct 30, 2009 | Oct 30, 2016 | Common Stock | 1,500,000 | 2,924,333 | D |
Explanation of responses
- F1In the original filing, the warrants converted were deducted from the incorrect warrant resulting in an incorrect warrant balance. The issue date, expiration date and exercise price are the same on the original filing and this amended filing.